advertisement
Quaranta L 287
Showing records 1 to 25 | Display only abstracts from Quaranta L in IGR 6-198041 Effect of COVID-19-related lockdown on ophthalmic practice in Italy: A report from 39 institutional centers
dell'Omo R; Filippelli M; Virgili G; Bandello F; Querques G; Lanzetta P; Avitabile T; Viola F; Viola F; Reibaldi M; Semeraro F; Quaranta L; Rizzo S; Midena E; Campagna G; Costagliola C;
European Journal of Ophthalmology 2022; 32: 695-703 (IGR: 22-4)
96056 A Comparison of Hyper-Reflective Retinal Spot Counts in Optical Coherence Tomography Images from Glaucomatous and Healthy Eyes
Quaranta L
Journal of clinical medicine 2021; 10: (IGR: 22-3)
96011 A new look at the safety and tolerability of prostaglandin analogue eyedrops in glaucoma and ocular hypertension
Katsanos A
Expert Opinion on Drug Safety 2021; 0: 1-15 (IGR: 22-3)
96056 A Comparison of Hyper-Reflective Retinal Spot Counts in Optical Coherence Tomography Images from Glaucomatous and Healthy Eyes
Bruttini C
Journal of clinical medicine 2021; 10: (IGR: 22-3)
96011 A new look at the safety and tolerability of prostaglandin analogue eyedrops in glaucoma and ocular hypertension
Riva I; Bozkurt B
Expert Opinion on Drug Safety 2021; 0: 1-15 (IGR: 22-3)
96056 A Comparison of Hyper-Reflective Retinal Spot Counts in Optical Coherence Tomography Images from Glaucomatous and Healthy Eyes
De Angelis G
Journal of clinical medicine 2021; 10: (IGR: 22-3)
96011 A new look at the safety and tolerability of prostaglandin analogue eyedrops in glaucoma and ocular hypertension
Holló G
Expert Opinion on Drug Safety 2021; 0: 1-15 (IGR: 22-3)
96056 A Comparison of Hyper-Reflective Retinal Spot Counts in Optical Coherence Tomography Images from Glaucomatous and Healthy Eyes
Montescani S
Journal of clinical medicine 2021; 10: (IGR: 22-3)
96011 A new look at the safety and tolerability of prostaglandin analogue eyedrops in glaucoma and ocular hypertension
Quaranta L
Expert Opinion on Drug Safety 2021; 0: 1-15 (IGR: 22-3)
96056 A Comparison of Hyper-Reflective Retinal Spot Counts in Optical Coherence Tomography Images from Glaucomatous and Healthy Eyes
Ardizzone A
Journal of clinical medicine 2021; 10: (IGR: 22-3)
96011 A new look at the safety and tolerability of prostaglandin analogue eyedrops in glaucoma and ocular hypertension
Oddone F
Expert Opinion on Drug Safety 2021; 0: 1-15 (IGR: 22-3)
96056 A Comparison of Hyper-Reflective Retinal Spot Counts in Optical Coherence Tomography Images from Glaucomatous and Healthy Eyes
Katsanos A; Carnevale C; Carnevale C
Journal of clinical medicine 2021; 10: (IGR: 22-3)
96011 A new look at the safety and tolerability of prostaglandin analogue eyedrops in glaucoma and ocular hypertension
Irkec M; Dutton GN
Expert Opinion on Drug Safety 2021; 0: 1-15 (IGR: 22-3)
96056 A Comparison of Hyper-Reflective Retinal Spot Counts in Optical Coherence Tomography Images from Glaucomatous and Healthy Eyes
Oddone F; Riva I
Journal of clinical medicine 2021; 10: (IGR: 22-3)
96011 A new look at the safety and tolerability of prostaglandin analogue eyedrops in glaucoma and ocular hypertension
Konstas AG
Expert Opinion on Drug Safety 2021; 0: 1-15 (IGR: 22-3)
94794 Confocal Microscopy and Anterior Segment Optical Coherence Tomography Imaging of the Ocular Surface and Bleb Morphology in Medically and Surgically Treated Glaucoma Patients: A Review
Carnevale C; Carnevale C
Pharmaceuticals (Basel, Switzerland) 2021; 14: (IGR: 22-2)
94572 Efficacy and Safety of PreserFlo MicroShunt After a Failed Trabeculectomy in Eyes with Primary Open-Angle Glaucoma: A Retrospective Study
Quaranta L; Micheletti E; Micheletti E
Advances in Therapy 2021; 38: 4403-4412 (IGR: 22-2)
94794 Confocal Microscopy and Anterior Segment Optical Coherence Tomography Imaging of the Ocular Surface and Bleb Morphology in Medically and Surgically Treated Glaucoma Patients: A Review
Riva I; Roberti G
Pharmaceuticals (Basel, Switzerland) 2021; 14: (IGR: 22-2)
94572 Efficacy and Safety of PreserFlo MicroShunt After a Failed Trabeculectomy in Eyes with Primary Open-Angle Glaucoma: A Retrospective Study
Carassa R
Advances in Therapy 2021; 38: 4403-4412 (IGR: 22-2)
94794 Confocal Microscopy and Anterior Segment Optical Coherence Tomography Imaging of the Ocular Surface and Bleb Morphology in Medically and Surgically Treated Glaucoma Patients: A Review
Michelessi M
Pharmaceuticals (Basel, Switzerland) 2021; 14: (IGR: 22-2)
94572 Efficacy and Safety of PreserFlo MicroShunt After a Failed Trabeculectomy in Eyes with Primary Open-Angle Glaucoma: A Retrospective Study
Bruttini C
Advances in Therapy 2021; 38: 4403-4412 (IGR: 22-2)
94794 Confocal Microscopy and Anterior Segment Optical Coherence Tomography Imaging of the Ocular Surface and Bleb Morphology in Medically and Surgically Treated Glaucoma Patients: A Review
Tanga L
Pharmaceuticals (Basel, Switzerland) 2021; 14: (IGR: 22-2)
94572 Efficacy and Safety of PreserFlo MicroShunt After a Failed Trabeculectomy in Eyes with Primary Open-Angle Glaucoma: A Retrospective Study
Fausto R; Katsanos A
Advances in Therapy 2021; 38: 4403-4412 (IGR: 22-2)
94794 Confocal Microscopy and Anterior Segment Optical Coherence Tomography Imaging of the Ocular Surface and Bleb Morphology in Medically and Surgically Treated Glaucoma Patients: A Review
Verticchio Vercellin AC
Pharmaceuticals (Basel, Switzerland) 2021; 14: (IGR: 22-2)
94572 Efficacy and Safety of PreserFlo MicroShunt After a Failed Trabeculectomy in Eyes with Primary Open-Angle Glaucoma: A Retrospective Study
Riva I
Advances in Therapy 2021; 38: 4403-4412 (IGR: 22-2)